Exhaled biomarkers can reveal lung disease

Date posted
Funding Agency
(Funded by the National Institutes of Health and the National Science Foundation)

Using specialized nanoparticles, MIT engineers have developed a way to monitor pneumonia or other lung diseases by analyzing the breath exhaled by the patient. In a study of mice, the researchers showed that they could use this system to monitor bacterial pneumonia and a genetic disorder of the lungs called alpha-1 antitrypsin deficiency.